Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
<0.036 <0.0015
EC/CAS
911-418-6/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
0.06%≤C<0.6 ≥0.6% 0.06%≤C<0.6 <0.0015
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0.0015
General Information
Version
5
Revision date
2025-10-21
Product name
SPECTRUM BLACKBOARD PAINT
1.2.1 Relevant identified uses
Professional use
1.2.2. Uses advised against
Consumer use
Emergency telephone
+31 (0)184 606299, +49 (0) 30 30686 700
Icons in SDS
Company Information
company name
Akzo Nobel Decorative Coatings BV
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Contains
1,2-benzisothiazol-3(2H)-one, CMIT/MIT(3 1) and 2-methyl-2H-isothiazol- 3-one. May produce an allergic reaction. Safety data sheet available on request.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 11 for more detailed information on health effects and symptoms.
